This formulation represents a significant innovation in the US market where formulations, such as PFIZER’s Solu-Cortef®, are effective solutions, yet require more than ten steps for ...
CROSSJECT enhanced its collaboration with Eton Pharmaceuticals, Inc. (“Eton”) by providing its proprietary innovative hydrocortisone formulation (the “CROSSJECT Formulation”) to enter the hospital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback